Silence Therapeutics (SLN) Research & Development (2024 - 2026)
Silence Therapeutics' Research & Development came in at $9.15 million for the quarter ended Jun 30, 2026, down 48.2% from $17.65 million a year earlier but up 0.3% from the prior quarter.
Silence Therapeutics (SLN) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Silence Therapeutics reported Research & Development of $47.56 million, down 41.1% year-over-year; for the year ended Dec 31, 2025, it came in at $67.75 million, down 0.2% from the prior year.
- Research & Development carries a five-year compound annual growth rate of 21.2% (years ended Dec 2020 to Dec 2025).
- Going back by year, Research & Development was $67.88 million in the year ended Dec 31, 2024 (+19.2%), $56.94 million in the year ended Dec 31, 2023 (+30.7%), $43.55 million in the year ended Dec 31, 2022 (+2.9%) and $42.33 million in the year ended Dec 31, 2021 (+63.1%).
- The five-year range for quarterly Research & Development is $8.75 million (the quarter ended Dec 31, 2025) to $22.08 million (the quarter ended Dec 31, 2024).
- Year-over-year, Research & Development has declined for three consecutive quarters, with an average decline of 9.9% over the last six quarters.
- Business Quant data shows SLN's Research & Development at $9.12 million (quarter ended Mar 31, 2026), $8.75 million (quarter ended Dec 31, 2025) and $20.54 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Silence Therapeutics | 932.92 Mn | 860.82 Mn | - | 9.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.15 Mn |
| Mar 31, 2026 | 9.12 Mn |
| Dec 31, 2025 | 8.75 Mn |
| Sep 30, 2025 | 20.54 Mn |
| Jun 30, 2025 | 17.65 Mn |
| Mar 31, 2025 | 20.81 Mn |
| Dec 31, 2024 | 22.08 Mn |
| Sep 30, 2024 | 20.16 Mn |
| Jun 30, 2024 | 13.80 Mn |
| Mar 31, 2024 | 11.85 Mn |
Silence Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();